Bioink as a critical component of 3D bioprinting is, 鈥渁 formulation of cells suitable for processing by an automated biofabrication technology that may also contain biologically active components and biomaterials鈥� (Groll et al., 2018). Bioinks are typically made up of cellular material, additives (growth factors, signaling molecules, etc.), and a supportive scaffold (mostly polymers), they should have proper mechanical, rheological, and biological properties of the target tissues.
Highlights
The global Bioinks market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Bioinks is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Bioinks is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Bioinks in Contract Research Organization (CRO) is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Bioinks include BICO, Allevi (3D Systems), Biogelx, RegenHU, InnoRegen, UPM Biomedicals, CollPlant, Brinter and BIO INK, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bioinks, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioinks.
The Bioinks market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bioinks market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bioinks companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
BICO
Allevi (3D Systems)
Biogelx
RegenHU
InnoRegen
UPM Biomedicals
CollPlant
Brinter
BIO INK
SunP Biotech
Regenovo
StemEasy
Zanasi Srl
Segment by Type
Matrix Bioinks
Sacrificial Bioinks
Support Bioinks
Others
Segment by Application
Contract Research Organization (CRO)
Pharma
CDMO
Clinical Research
Academic Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bioinks companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Bioinks 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Matrix Bioinks
1.2.3 Sacrificial Bioinks
1.2.4 Support Bioinks
1.2.5 Others
1.3 麻豆原创 by Application
1.3.1 Global Bioinks 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Contract Research Organization (CRO)
1.3.3 Pharma
1.3.4 CDMO
1.3.5 Clinical Research
1.3.6 Academic Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bioinks 麻豆原创 Perspective (2018-2029)
2.2 Bioinks Growth Trends by Region
2.2.1 Global Bioinks 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Bioinks Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Bioinks Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Bioinks 麻豆原创 Dynamics
2.3.1 Bioinks Industry Trends
2.3.2 Bioinks 麻豆原创 Drivers
2.3.3 Bioinks 麻豆原创 Challenges
2.3.4 Bioinks 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bioinks Players by Revenue
3.1.1 Global Top Bioinks Players by Revenue (2018-2023)
3.1.2 Global Bioinks Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Bioinks 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bioinks Revenue
3.4 Global Bioinks 麻豆原创 Concentration Ratio
3.4.1 Global Bioinks 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bioinks Revenue in 2022
3.5 Bioinks Key Players Head office and Area Served
3.6 Key Players Bioinks Product Solution and Service
3.7 Date of Enter into Bioinks 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Bioinks Breakdown Data by Type
4.1 Global Bioinks Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Bioinks Forecasted 麻豆原创 Size by Type (2024-2029)
5 Bioinks Breakdown Data by Application
5.1 Global Bioinks Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Bioinks Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Bioinks 麻豆原创 Size (2018-2029)
6.2 North America Bioinks 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Bioinks 麻豆原创 Size by Country (2018-2023)
6.4 North America Bioinks 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bioinks 麻豆原创 Size (2018-2029)
7.2 Europe Bioinks 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Bioinks 麻豆原创 Size by Country (2018-2023)
7.4 Europe Bioinks 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bioinks 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Bioinks 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Bioinks 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Bioinks 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bioinks 麻豆原创 Size (2018-2029)
9.2 Latin America Bioinks 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Bioinks 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Bioinks 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bioinks 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Bioinks 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Bioinks 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Bioinks 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BICO
11.1.1 BICO Company Detail
11.1.2 BICO Business Overview
11.1.3 BICO Bioinks Introduction
11.1.4 BICO Revenue in Bioinks Business (2018-2023)
11.1.5 BICO Recent Development
11.2 Allevi (3D Systems)
11.2.1 Allevi (3D Systems) Company Detail
11.2.2 Allevi (3D Systems) Business Overview
11.2.3 Allevi (3D Systems) Bioinks Introduction
11.2.4 Allevi (3D Systems) Revenue in Bioinks Business (2018-2023)
11.2.5 Allevi (3D Systems) Recent Development
11.3 Biogelx
11.3.1 Biogelx Company Detail
11.3.2 Biogelx Business Overview
11.3.3 Biogelx Bioinks Introduction
11.3.4 Biogelx Revenue in Bioinks Business (2018-2023)
11.3.5 Biogelx Recent Development
11.4 RegenHU
11.4.1 RegenHU Company Detail
11.4.2 RegenHU Business Overview
11.4.3 RegenHU Bioinks Introduction
11.4.4 RegenHU Revenue in Bioinks Business (2018-2023)
11.4.5 RegenHU Recent Development
11.5 InnoRegen
11.5.1 InnoRegen Company Detail
11.5.2 InnoRegen Business Overview
11.5.3 InnoRegen Bioinks Introduction
11.5.4 InnoRegen Revenue in Bioinks Business (2018-2023)
11.5.5 InnoRegen Recent Development
11.6 UPM Biomedicals
11.6.1 UPM Biomedicals Company Detail
11.6.2 UPM Biomedicals Business Overview
11.6.3 UPM Biomedicals Bioinks Introduction
11.6.4 UPM Biomedicals Revenue in Bioinks Business (2018-2023)
11.6.5 UPM Biomedicals Recent Development
11.7 CollPlant
11.7.1 CollPlant Company Detail
11.7.2 CollPlant Business Overview
11.7.3 CollPlant Bioinks Introduction
11.7.4 CollPlant Revenue in Bioinks Business (2018-2023)
11.7.5 CollPlant Recent Development
11.8 Brinter
11.8.1 Brinter Company Detail
11.8.2 Brinter Business Overview
11.8.3 Brinter Bioinks Introduction
11.8.4 Brinter Revenue in Bioinks Business (2018-2023)
11.8.5 Brinter Recent Development
11.9 BIO INK
11.9.1 BIO INK Company Detail
11.9.2 BIO INK Business Overview
11.9.3 BIO INK Bioinks Introduction
11.9.4 BIO INK Revenue in Bioinks Business (2018-2023)
11.9.5 BIO INK Recent Development
11.10 SunP Biotech
11.10.1 SunP Biotech Company Detail
11.10.2 SunP Biotech Business Overview
11.10.3 SunP Biotech Bioinks Introduction
11.10.4 SunP Biotech Revenue in Bioinks Business (2018-2023)
11.10.5 SunP Biotech Recent Development
11.11 Regenovo
11.11.1 Regenovo Company Detail
11.11.2 Regenovo Business Overview
11.11.3 Regenovo Bioinks Introduction
11.11.4 Regenovo Revenue in Bioinks Business (2018-2023)
11.11.5 Regenovo Recent Development
11.12 StemEasy
11.12.1 StemEasy Company Detail
11.12.2 StemEasy Business Overview
11.12.3 StemEasy Bioinks Introduction
11.12.4 StemEasy Revenue in Bioinks Business (2018-2023)
11.12.5 StemEasy Recent Development
11.13 Zanasi Srl
11.13.1 Zanasi Srl Company Detail
11.13.2 Zanasi Srl Business Overview
11.13.3 Zanasi Srl Bioinks Introduction
11.13.4 Zanasi Srl Revenue in Bioinks Business (2018-2023)
11.13.5 Zanasi Srl Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
BICO
Allevi (3D Systems)
Biogelx
RegenHU
InnoRegen
UPM Biomedicals
CollPlant
Brinter
BIO INK
SunP Biotech
Regenovo
StemEasy
Zanasi Srl
听
听
*If Applicable.
